Appendix

약어집

Abbreviation	a key to Abbreviations
ABR	Absolute bed rest
AGP	Antegrade pyelography
A-line	Arterial line
Anti.	Antibiotics
ARF	Acute renal failure
BM	Bone marrow
BR	Bed rest
BST	Blood sugar test
BT	Bleeding time
BWt	Body weight
Bx	Biopsy
C-line	Central line
CRF	Chronic renal failure
CrCl	Creatinine clearance
CVP	Central venous pressure
DIC	Disseminated intravascular coagulation
D-J	Double-J catheter
E'	Electrolyte
FBS	Fasting blood glucose
FFP	Fresh frozen plasma
F/U	Follow up
G.O	Gas out
Hb	Hemoglobin
Hct	Hematocrit
HD	Hemodialysis
H/S	Hartman solution
HTN	Hypertension
I/O	Input/Output
IV	Intravenous
LD	Liquid diet
LFT	Liver function test
L-tube	Levin tube
NRD	Normal regular diet
N/S	Normal saline
OP	Operation
OSM	Osmolarity
P/C	Platelet concentrate
PCA	Patient-controlled analgesia
PCN	Percutaneous nephrostomy
PFT	Pulmonary function test
PO	By mouth, orally
POD	Post-operative day
PSA	Prostate specific antigen
PT	Prothrombin time
qd	Once daily
RGP	Retrograde pyelography
SD	Soft diet
SOW	Seeps of water
TD	Tolerable diet
TPN	Total parenteral nutrition
TURB	Transurethral resection of bladder
TURP	Transurethral resection of prostate
U.O	Urine output
USG	Ultrasonography
V/S	Vital sign
W/B	Whole blood
W/U	Work up

비뇨기계 종양의 병기

Kidney cancer TNM staging AJCC UICC 2017

Primary tumor (T)

T category	T criteria
TX	Primary tumor cannot be assessed
T0	No evidence of primary tumor
T1	Tumor ≤7 cm in greatest dimension, limited to the kidney
T1a	Tumor ≤4 cm in greatest dimension, limited to the kidney
T1b	Tumor >4 cm but ≤7 cm in greatest dimension, limited to the kidney
T2	Tumor >7 cm in greatest dimension, limited to the kidney
T2a	Tumor >7 cm but ≤10 cm in greatest dimension, limited to the kidney
T2b	Tumor >10 cm, limited to the kidney
T3	Tumor extends into major veins or perinephric tissues, but not into the ipsilateral adrenal gland and not beyond Gerota's fascia
T3a	Tumor extends into the renal vein or its segmental branches, or invades the pelvicalyceal system, or invades perirenal and/or renal sinus fat but not beyond Gerota's fascia
T3b	Tumor extends into the vena cava below the diaphragm
T3c	Tumor extends into the vena cava above the diaphragm or invades the wall of the vena cava
T4	Tumor invades beyond Gerota's fascia (including contiguous extension into the ipsilateral adrenal gland)
Regional lymph nodes (N)
N category	N criteria
NX	Regional lymph nodes cannot be assessed
N0	No regional lymph node metastasis
N1	Metastasis in regional lymph node(s)
Distant metastasis (M)
M category	M criteria
M0	No distant metastasis
M1	Distant metastasis
Prognostic stage groups
When T is...	And N is...	And M is...	Then the stage group is...
T1	N0	M0	I
T1	N1	M0	III
T2	N0	M0	II
T2	N1	M0	III
T3	NX, N0	M0	III
T3	N1	M0	III
T4	Any N	M0	IV
Any T	Any N	M1	IV

TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control.

Tumors of the renal pelvis and ureter TNM staging AJCC UICC 2017

Primary tumor (T)

T category	T criteria
TX	Primary tumor cannot be assessed
T0	No evidence of primary tumor
Ta	Noninvasive papillary carcinoma
Tis	Urothelial carcinoma in situ: "Flat tumor"
T1	Tumor invades lamina propria (subepithelial connective tissue)
T2	Tumor invades muscularis propria
pT2a	Tumor invades superficial muscularis propria (inner half)
pT2b	Tumor invades deep muscularis propria (outer half)
T3	Tumor invades perivesical soft tissue
pT3a	Microscopically
pT3b	Macroscopically (extravesical mass)
T4	Extravesical tumor directly invades any of the following: Prostatic stroma, seminal vesicles, uterus, vagina, pelvic wall, abdominal wall
T4a	Extravesical tumor invades directly into prostatic stroma, uterus, vagina
T4b	Extravesical tumor invades pelvic wall, abdominal wall
Regional lymph nodes (N)
N category	N criteria
NX	Lymph nodes cannot be assessed
N0	No lymph node metastasis
N1	Single regional lymph node metastasis in the true pelvis (perivesical, obturator, internal and external iliac, or sacral lymph node)
N2	Multiple regional lymph node metastasis in the true pelvis (perivesical, obturator, internal and external iliac, or sacral lymph node metastasis)
N3	Lymph node metastasis to the common iliac lymph nodes
Distant metastasis (M)
M category	M criteria
M0	No distant metastasis
M1	Distant metastasis
M1a	Distant metastasis limited to lymph nodes beyond the common iliacs
M1b	Non-lymph-node distant metastases
Prognostic stage groups
When T is...	And N is...	And M is...	Then the stage group is...
Ta	N0	M0	0a
Tis	N0	M0	0is
T1	N0	M0	I
T2a	N0	M0	II
T3a, T3b, T4a	N0	M0	IIIA
T1-T4a	N1	M0	IIIA
T1-T4a	N2, N3	M0	IIIB
T4b	Any N	M0	IVA
Any T	Any N	M1a	IVA
Any T	Any N	M1b	IVB

TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control.

Bladder cancer TNM staging AJCC UICC 2017

Primary tumor (T)

T category	T criteria
TX	Primary tumor cannot be assessed
T0	No evidence of primary tumor
Ta	Noninvasive papillary carcinoma
Tis	Urothelial carcinoma in situ: "Flat tumor"
T1	Tumor invades lamina propria (subepithelial connective tissue)
T2	Tumor invades muscularis propria
pT2a	Tumor invades superficial muscularis propria (inner half)
pT2b	Tumor invades deep muscularis propria (outer half)
T3	Tumor invades perivesical soft tissue
pT3a	Microscopically
pT3b	Macroscopically (extravesical mass)
T4	Extravesical tumor directly invades any of the following: Prostatic stroma, seminal vesicles, uterus, vagina, pelvic wall, abdominal wall
T4a	Extravesical tumor invades directly into prostatic stroma, uterus, vagina
T4b	Extravesical tumor invades pelvic wall, abdominal wall
Regional lymph nodes (N)
N category	N criteria
NX	Lymph nodes cannot be assessed
N0	No lymph node metastasis
N1	Single regional lymph node metastasis in the true pelvis (perivesical, obturator, internal and external iliac, or sacral lymph node
N2	Multiple regional lymph node metastasis in the true pelvis (perivesical, obturator, internal and external iliac, or sacral lymph node metastasis)
N3	Lymph node metastasis to the common iliac lymph nodes
Distant metastasis (M)
M category	M criteria
M0	No distant metastasis
M1	Distant metastasis
M1a	Distant metastasis limited to lymph nodes beyond the common iliacs
M1b	Non-lymph-node distant metastases
Prognostic stage groups
When T is...	And N is...	And M is...	Then the stage group is...
Ta	N0	M0	0a
Tis	N0	M0	0is
T1	N0	M0	I
T2a	N0	M0	II
T2b	N0	M0	II
T3a, T3b, T4a	N0	M0	IIIA
T1-T4a	N1	M0	IIIA
T1-T4a	N2, N3	M0	IIIB
T4b	Any N	M0	IVA
Any T	Any N	M1a	IVA
Any T	Any N	M1b	IVB

TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control.

Prostate cancer TNM staging AJCC UICC 2017

Primary tumor (T)

Clinical T (cT)
T category	T criteria
TX	Primary tumor cannot be assessed
T0	No evidence of primary tumor
T1	Clinically inapparent tumor that is not palpable
T1a	Tumor incidental histologic finding in 5% or less of tissue resected
T1b	Tumor incidental histologic finding in more than 5% of tissue resected
T1c	Tumor identified by needle biopsy found in one or both sides, but not palpable
T2	Tumor is palpable and confined within prostate
T2a	Tumor involves one-half of one side or less
T2b	Tumor involves more than one-half of one side but not both sides
T2c	Tumor involves both sides
T3	Extraprostatic tumor that is not fixed or does not invade adjacent structures
T3a	Extraprostatic extension (unilateral or bilateral)
T3b	Tumor invades seminal vesicle(s
T4	Tumor is fixed or invades adjacent structures other than seminal vesicles such as external sphincter, rectum, bladder, levator muscles, and/or pelvic wall
Pathological T (pT)
T category	T criteria
T2	Organ confined
T3	Extraprostatic extension
T3a	Extraprostatic extension (unilateral or bilateral) or microscopic invasion of bladder neck
T3b	Tumor invades seminal vesicle(s)
T4	Tumor is fixed or invades adjacent structures other than seminal vesicles such as external sphincter, rectum, bladder, levator muscles, and/or pelvic wall
NOTE: There is no pathological T1 classification. NOTE: Positive surgical margin should be indicated by an R1 descriptor, indicating residual microscopic disease.
Regional lymph nodes (N)
N category	N criteria
NX	Regional nodes were not assessed
N0	No positive regional nodes
N1	Metastases in regional node(s
Distant metastasis (M)
M1a	Nonregional lymph node(s)
M1b	Bone(s)
M1c	Other site(s) with or without bone disease
NOTE: When more than one site of metastasis is present, the most advanced category is used. M1c is most advanced.
Prostate-specific antigen (PSA)
PSA values are used to assign this category.
PSA values
<10
≥10 <20
<20
≥20
Any value
Histologic grade group (G)
Recently, the Gleason system has been compressed into so-called Grade Groups.
Grade Group	Gleason score	Gleason pattern
1	≤6	≤3+3
2	7	3+4
3	7	4+3
4	8	4+4, 3+5, 5+3
5	9 or 10	4+5, 5+4, or 5+5

TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control.

Testicular cancer TNM staging AJCC UICC 2017

Primary tumor (T)

Clinical T (cT)
cT category	cT criteria
cTX	Primary tumor cannot be assessed
cT0	No evidence of primary tumor
cTis	Germ cell neoplasia in situ
cT4	Tumor invades scrotum with or without vascular/lymphatic invasion
NOTE: Except for Tis confirmed by biopsy and T4, the extent of the primary tumor is classified by radical orchiectomy. TX may be used for other categories for clinical staging.
Pathological T (pT)
pT category	pT criteria
pTX	Primary tumor cannot be assessed
pT0	No evidence of primary tumor
pTis	Germ cell neoplasia in situ
pT1	Tumor limited to testis (including rete testis invasion) without lymphovascular invasion
pT1a*	Tumor smaller than 3 cm in size
pT1b*	Tumor 3 cm or larger in size
pT2	Tumor limited to testis (including rete testis invasion) with lymphovascular invasion or Tumor invading hilar soft tissue or epididymis or penetrating visceral mesothelial layer covering the external surface of tunica albuginea with or without lymphovascular invasion
pT3	Tumor invades spermatic cord with or without lymphovascular invasion
pT4	Tumor invades scrotum with or without lymphovascular invasion
* Subclassification of pT1 applies only to pure seminoma.
Regional lymph nodes (N)
Clinical N (cN)
cN category	cN criteria
cNX	Regional lymph nodes cannot be assessed
cN0	No regional lymph node metastasis
cN1	Metastases with a lymph node mass 2 cm or smaller in greatest dimension or Multiple lymph nodes, none larger than 2 cm in greatest dimension
cN2	Metastasis with a lymph node mass larger than 2 cm but not larger than 5 cm in greatest dimension or Multiple lymph nodes, any one mass larger than 2 cm but not larger than 5 cm in greatest dimension
cN3	Metastasis with a lymph node mass larger than 5 cm in greatest dimension
Pathological N (pN)
pN category	pN criteria
pNX	Regional lymph nodes cannot be assessed
pN0	No regional lymph node metastasis
pN1	Metastasis with a lymph node mass 2 cm or smaller in greatest dimension and less than or equal to five nodes positive, none larger than 2 cm in greatest dimension
pN2	Metastasis with a lymph node mass larger than 2 cm but not larger than 5 cm in greatest dimension; or more than more than five nodes positive, none larger than 5 cm; or evidence of extranodal extension of tumor
pN3	Metastasis with a lymph node mass larger than 5 cm in greatest dimension
Distant metastasis (M)
M category	M criteria
M0	No distant metastases
M1	Distant metastases
M1a	Non-retroperitoneal nodal or pulmonary metastases
M1b	Non-pulmonary visceral metastases
Serum markers (S)
S category	S criteria
SX	Marker studies not available or not performed
S0	Marker study levels within normal limits
S1	LDH <1.5 x N¶ and hCG (mIU/mL) <5000 and AFP (ng/mL) <1000
S2	LDH 1.5-10 x N¶ or hCG (mIU/mL) 5000-50,000 or AFP (ng/ mL) 1000-10,000
S3	LDH >10 x N¶ or hCG (mIU/mL) >50,000 or AFP (ng/mL) >10,000
¶ N indicates the upper limit of normal for the LDH assay

TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control; LDH: lactate dehydrogenase; hCG: human chorionic gonadotropin; AFP: alphafetoprotein.

Urethral cancer TNM staging AJCC UICC 2017

Primary tumor (T)

Male penile urethra and female urethra
T category	T criteria
TX	Primary tumor cannot be assessed
T0	No evidence of primary tumor
Ta	Non-invasive papillary carcinoma
Tis	Carcinoma in situ
T1	Tumor invades subepithelial connective tissue
T2	Tumor invades any of the following: Corpus spongiosum, periurethral muscle
T3	Tumor invades any of the following: Corpus cavernosum, anterior vagina
T4	Tumor invades other adjacent organs (eg, invasion of the bladder wall)
Prostatic urethra
T category	T criteria
Tis	Carcinoma in situ involving the prostatic urethra or periurethral or prostatic ducts without stromal invasion
T1	Tumor invades urethral subepithelial connective tissue immediately underlying the urothelium
T2	Tumor invades the prostatic stroma surrounding ducts either by direct extension from the urothelial surface or by invasion from prostatic ducts
T3	Tumor invades the periprostatic fat
T4	Tumor invades other adjacent organs (eg, extraprostatic invasion of the bladder wall, rectal wall)
Regional lymph nodes (N)
N category	N criteria
NX	Regional lymph nodes cannot be assessed
N0	No regional lymph node metastasis
N1	Single regional lymph node metastasis in the inguinal region or true pelvis (perivesical, obturator, internal [hypogastric] and external iliac), or presacral lymph node
N2	Multiple regional lymph node metastasis in the inguinal region or true pelvis (perivesical, obturator, internal [hypogastric] and external iliac), or presacral lymph node
Distant metastasis (M)
M category	M criteria
M0	No distant metastasis
M1	Distant metastasis

TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control.

Cancer of the penis TNM staging AJCC UICC 2017

Primary tumor (T)

T category	T criteria
TX	Primary tumor cannot be assessed
T0	No evidence of primary tumor
Tis	Carcinoma in situ (penile intraepithelial neoplasia [PeIN])
Ta	Noninvasive localized squamous cell carcinoma
T1	Glans: Tumor invades lamina propria. Foreskin: Tumor invades dermis, lamina propria, or dartos fascia. Shaft: Tumor invades connective tissue between epidermis and corpora regardless of location. All sites with or without lymphovascular invasion or perineural invasion and is or is not high grade.
T1a	Tumor is without lymphovascular invasion or perineural invasion and is not high grade (ie, grade 3 or sarcomatoid)
T1b	Tumor exhibits lymphovascular invasion and/or perinerual invasion or is high grade (ie, grade 3 or sarcomatoid)
T2	Tumor invades into corpus spongiosum (either glans or ventral shaft) with or without urethral invasion
T3	Tumor invades into corpa cavernosum (including tunica albuginea) with or without urethral invasion
T4	Tumor invades into adjacent structures (ie, scrotum, prostate, pubic bone)
Regional lymph nodes (N)
Clinical N (cN)
cN category	cN criteria
cNX	Regional lymph nodes cannot be assessed
cN0	No palpable or visibly enlarged inguinal lymph nodes
cN1	Palpable mobile unilateral inguinal lymph node
cN2	Palpable mobile ≥2 unilateral inguinal nodes or bilateral inguinal lymph nodes
cN3	Palpable fixed inguinal nodal mass or pelvic lymphadenopathy unilateral or bilateral
Pathological N (pN)
pN category	pN criteria
pNX	Lymph node metastasis cannot be established
pN0	No lymph node metastasis
pN1	≤2 unilateral inguinal metastases, no ENE
pN2	≥3 unilateral inguinal metastases or bilateral metastases
pN3	ENE of lymph node metastases or pelvic lymph node metastases
Distant metastasis (M)
M category	M criteria
M0	No distant metastasis
M1	Distant metastasis present

TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control; ENE: extranodal extension.

실험실검사 참조수치

TABLE 1. Hematology and Coagulation

Analyte		Specimen	SI Units	Conventional Units
Bleeding time (adult)			<7.1 mi	<7.1min
Clot retraction		WB	0.50-1.00/2h	50-100%/2h
Cryofibrinogen		P	Negative	Negative
D-dimer		P	220-740ng/mL FEU	220-740ng/mL FEU
Differential blood count		WB
Relative counts:
	Neutrophils		0.40-0.70	40-70%
	Bands		0.0-0.05	0-5%
	Lymphocytes		0.20-0.50	20-50%
	Monocytes		0.04-0.08	4-8%
	Eosinophils		0.0-0.6	0-6%
	Basophils		0.0-0.02	0-2%
Absolute counts:
	Neutrophils		1.42-6.34×109 /L	1420-6340/mm3
	Bands		0-0.45×109 /L	0-450/mm3
	Lymphocytes		0.71-4.53×109 /L	710-4530/mm3
	Monocytes		0.14-0.72×109 /L	140-720/mm3
	Eosinophils		0-0.54×109 /L	0-540/mm3
	Basophils		0-0.18×109 /L	0-180/mm3
Erythrocyte count		WB
	Adult males		4.30-5.60×1012/L	4.30-5.60×106 /mm3
	Adult females		4.00-5.20×1012/L	4.00-5.20×106 /mm3
Erythrocyte life span		WB
	Normal survival		120days	120days
	Chromium labeled, half-life (t1/2)		25-35days	25-35days
Erythrocyte sedimentation rate		WB
	Females		0-20mm/h	0-20mm/h
	Males		0-15mm/h	0-15mm/h
Hematocrit		WB
	Adult males		0.388-0.464	38.8-46.4
	Adult females		0.354-0.444	35.4-44.4
Hemoglobin
	Plasma	P	6-50mg/L	0.6-5.0mg/dL
	Whole blood:	WB
	Adult males		133-162g/L	13.3-16.2g/dL
	Adult females		120-158g/L	12.0-15.8g/dL
Leukocytes		WB
	Count (WBC)		3.54-9.06×109 /L	3.54-9.06×103 /mm3
Mean corpuscular hemoglobin (MCH)		WB	26.7-31.9pg/cell	26.7-31.9pg/cell
Mean corpuscular hemoglobin concentration (MCHC)		WB	323-359g/L	32.3-35.9g/dL
Mean corpuscular hemoglobin of reticulocytes (CH)		WB	24-36pg	24-36pg
Mean corpuscular volume (MCV)		WB	79-93.3fL	79-93.3μm3
Mean platelet volume (MPV)		WB	9.00-12.95fL	9.00-12.95
Partial thromboplastin time, activated		P	26.3-39.4s	26.3-39.4s
Platelet count		WB	165-415×109 /L	165-415×103 /mm3
Prothrombin time		P	2.7-15.4s	12.7-15.4s
Red cell distribution width		WB	<0.145	<14.5%
Reptilase time		P	16-23.6s	16-23.6s
Thrombin time		P	15.3-18.5s	15.3-18.5s
Total eosinophils		WB	150-300×106 /L	150-300/mm3

TABLE 2. Clinical Chemistry and Immunology

Analyte			Specimen	SI Units	Conventional Units
Acetoacetate			P	49-294μmol/L	0.5-3.0mg/dL
Adrenocorticotropin (ACTH)			P	1.3-16.7pmol/L	6.0-76.0pg/mL
Alanine aminotransferase (ALT, SGPT)			S	0.12-0.70μkat/L	7-41U/L
Albumin			S	40-50g/L	4.0-5.0mg/dL
Aldolase			S	26-138nkat/L	1.5-8.1U/L
Aldosterone (adult)
	Supine, normal sodium diet		S, P	<443pmol/L	<16ng/dL
	Upright, normal		S, P	111-858pmol/L	4-31ng/dL
Alpha fetoprotein (adult)				0-8.5μg/L	0-8.5ng/mL
Alpha1 antitrypsin				1.0-2.0g/L	100-200mg/dL
Ammonia, as NH3				11-35μmol/L	19-60 μg/dL
Amylase				0.34-1.6 μkat/L	20-96U/L
Androstendione (adult)
	Males			0.81-3.1nmol/L	23-89ng/dL
	Females
		Premenopausal		0.91-7.5nmol/L	26-214ng/dL
		Postmenopausal		0.46-2.9nmol/L	13-82ng/dL
Angiotensin-converting enzyme (ACE)			S	0.15-1.1μkat/L	9-67U/L
Anion gap			S	7-16mmol/L	7-16mmol/L
Apolipoprotein A-1			S
	Male			0.94-1.78g/L	94-178mg/dL
	Female			1.01-1.99g/L	101-199mg/dL
Apolipoprotein B			S
	Male			0.55-1.40g/L	55-140mg/dL
	Female			0.55-1.25g/L	55-125mg/dL
Arterial blood gases			WB
	[HCO3- ]			22-30mmol/L	22-30meq/L
	PCO2			4.3-6.0kPa	32-45mmHg
	pH			7.35-7.45	7.35-7.45
	PO2			9.6-13.8kPa	72-104mmHg
Aspartate aminotransferase (AST, SGOT)			S	0.20-0.65μkat/L	12-38U/L
B-type natriuretic peptide (BNP)			P	Age and gender specific: <100ng/L	Age and gender specific: <100pg/mL
Bilirubin			S
	Total			5.1-22μmol/L	0.3-1.3mg/dL
	Direct			1.7-6.8μmol/L	0.1-0.4mg/dL
	Indirect			3.4-15.2μmol/L	0.2-0.9mg/dL
C peptide			S	0.27-1.19nmol/L	0.8-3.5ng/mL
	C1-esterase-inhibitor protein		S	210-390mg/L	21-39mg/dL
CA 125			S	<35kU/L	<35U/mL
CA 19-9			S	<37kU/L	<37U/mL
CA 15-3			S	<33kU/L	<33U/mL
CA 27-29			S	0-40kU/L	0-40U/mL
Calcitonin			S
	Male			0-7.5ng/L	0-7.5pg/mL
	Female			0-5.1ng/L	0-5.1pg/mL
Calcium			S	2.2-2.6mmol/L	8.7-10.2mg/dL
	Calcium, ionized		WB	1.12-1.32mmol/L	4.5-5.3mg/dL
Carbon dioxide content (TCO2)			P (sea level)	22-30mmol/L	22-30meq/L
Carboxyhemoglobin (carbon monoxide content)			WB
	Nonsmokers			0.0-0.015	0-1.5%
	Smokers			0.04-0.09	4-9%
Loss of consciousness and death				>0.50	>50%
Carcinoembryonic antigen (CEA)			S
		Nonsmokers		0.0-3.0μg/L	0.0-3.0ng/mL
		Smokers		0.0-5.0μg/L	0.0-5.0ng/mL
	Ceruloplasmin		S	250-630mg/L	25-63mg/dL
	Chloride		S	102-109mmol/L	102-109meq/L
Cholinesterase			S	5-12kU/L	5-12U/mL
Chromogranin A			S	0-50μg/L	0-50ng/mL
Complement			S
	C3			0.83-1.77g/L	83-177mg/dL
	C4			0.16-0.47g/L	16-47mg/dL
Complement total				60-144CAE units	60-144CAE units
Cortisol			S
	Fasting, 8 A.M.-12 noon			138-690nmol/L	5-25μg/dL
	12 noon-8 P.M			138-414nmol/L	5-15μg/dL
	8 P.M.-8 A.M			0-276nmol/L	0-10μg/dL
	C-reactive protein		S	<10mg/L	<10mg/L
	C-reactive protein, high sensitivity		S	Cardiac risk	Cardiac risk
				Low: <1.0mg/L	Low: <1.0mg/L
				Average: 1.0-3.0mg/L	Average: 1.0-3.0mg/L
				High: >3.0mg/L	High: >3.0mg/L
Creatine kinase (total)			S
	Females			0.66-4.0μkat/L	39-238U/L
	Males			0.87-5.0μkat/L	51-294U/L
Creatine kinase-MB			S
	Mass			0.0-5.5μg/L	0.0-5.5ng/mL
	Fraction of total activity (by electrophoresis)			0-0.04	0-4.0%
Creatinine			S
	Female			44-80μmol/L	0.5-0.9mg/dL
	Male			53-106μmol/L	0.6-1.2mg/dL
Dehydroepiandrosterone (DHEA) (adult)			S
	Male			6.2-43.4nmol/L	180-1250ng/dL
	Female			4.5-34.0nmol/L	130-980ng/dL
Dehydroepiandrosterone (DHEA) sulfate			S
	Male (adult)			100-6190μg/L	10-619μg/dL
	Female (adult, premenopausal)			120-5350μg/L	12-535μg/dL
	Female (adult, postmenopausal)			300-2600μg/L	30-260μg/dL
	11-Deoxycortisol (adult)(compound S)		S	0.34-4.56nmol/L	12-158ng/dL
Dihydrotestosterone			S, P
	Male			1.03-2.92nmol/L	30-85ng/dL
	Female			0.14-0.76nmol/L	4-22ng/dL
Dopamine			P	0-130pmol/L	0-20pg/mL
Epinephrine			P
	Supine (30 min)			<273pmol/L	<50pg/mL
	Sitting			<328pmol/L	<60pg/mL
	Standing (30 min)			<491pmol/L	<90pg/mL
Erythropoietin			S	4-27U/L	4-27U/L
Estradiol			S, P
	Female
	Menstruating:
		Follicular phase		74-532pmol/L	<20-145pg/mL
		Midcycle peak		411-1626pmol/L	112-443pg/mL
		Luteal phase		74-885pmol/L	<20-241pg/mL
	Postmenopausal			217pmol/L	<59pg/mL
	Male			74pmol/L	<20pg/mL
Estrone			S, P
	Female
	Menstruating:
		Follicular phase		<555pmol/L	<150pg/mL
		Luteal phase		<740pmol/L	<200pg/mL
		Postmenopausal		11-118pmol/L	3-32pg/mL
	Male			33-133pmol/L	9-36pg/mL
	Fatty acids, free (nonesterified)		P	0.1-0.6mmol/L	2.8-16.8mg/dL
Ferritin			S
	Female			10-150μg/L	10-150ng/mL
	Male			29-248μg/L	29-248ng/mL
Follicle-stimulating hormone (FSH) S, P
	Female
		Menstruating
		Follicular phase		3.0-20.0IU/L	3.0-20.0mIU/mL
		Ovulatory phase		9.0-26.0IU/L	9.0-26.0mIU/mL
		Luteal phase		1.0-12.0IU/L	1.0-12.0mIU/mL
		Postmenopausal		18.0-153.0IU/L	18.0-153.0mIU/mL
	Male			1.0-12.0IU/L	1.0-12.0mIU/mL
	Fructosamine		S	<285umol/L	<285umol/L
Gamma glutamyltransferase			S	0.15-0.99μkat/L	9-58U/L
	Gastrin		S	<100ng/L	<100pg/mL
Glucagon			P	40-130ng/L	40-130pg/mL
Glucose			WB	3.6-5.3mmol/L	65-95mg/dL
Glucose (fasting)			P
	Normal			4.2-5.6mmol/L	75-100mg/dL
	Increased risk for diabetes			5.6-6.9mmol/L	100-125mg/dL
Diabetes mellitus				Fasting ≥7.0 mmol/L	Fasting ≥126mg/dL
				A 2-hour level of ≥11.1mmol/L during an oral glucose tolerance	A 2-hour level of ≥ 200mg/dL during an oral glucose
				test	tolerance test
				A random glucose level of ≥11.1mmol/L in patients with symptoms of hyperglycemia	A random glucose level of ≥200mg/dL in patients with symptoms of hyperglycemia
	Growth hormone		S	0-5μg/L	0-5ng/mL
Hemoglobin A1c			WB
	Pre-diabetes			0.04-0.06 HgB fraction	4.0-5.6%
	Diabetes mellitus			0.057-0.064 HgB fraction	5.7-6.4%
				A hemoglobin A1c level of ≥0.065 Hgb fraction as suggestedby the American Diabetes Association	A hemoglobin A1c level of ≥6.5% as suggested by the American Diabetes Association
Hemoglobin A1c with estimated average			WB	eAg mmoL/L=	eAg (mg/dL)=
	glucose (eAg)			1.59×HbA1c-2.59	28.7×HbA1c-46.7
Human chorionic gonadotropin (HCG)			S
	Nonpregnant female			<5IU/L	<5mIU/ml
	1-2weeks postconception			9-130IU/L	9-130mIU/mL
	2-3weeks postconception			75-2600IU/L	75-2600mIU/mL
	3-4weeks postconception			850-20,800IU/L	850-20,800mIU/mL
	4-5weeks postconception			4,000-100,200IU/L	4,000-100,200mIU/mL
	5-10weeks postconception			11,500-289,000IU/L	11,500-289,000mIU/mL
	10-14weeks post conception			18,300-137,000IU/L	18,300-137,000mIU/mL
	Second trimester			1,400-53,000 U/L	1400-53,000mIU/mL
Third trimester				940-60,000IU/L	940-60,000mIU/mL
β-Hydroxybutyrate			P	60-170μmol/L	0.6-1.8mg/dL
17-Hydroxyprogesterone (adult)			S
	Male			<4.17nmol/L	<139ng/dL
	Female
		Follicular phase		0.45-2.1nmol/L	15-70ng/dL
		Luteal phase		1.05-8.7nmol/L	35-290ng/dL
Lactate			P, arterial	0.5-1.6mmol/L	4.5-14.4mg/dL
			P, venous	0.5-2.2mmol/L	4.5-19.8mg/dL
Lactate dehydrogenase			S	2.0-3.8μkat/L	115-221U/L
Lipase			S	0.51-0.73μkat/L	3-43U/L
	Lipoprotein (a)		S	0-300mg/L	0-30mg/dL
Luteinizing hormone (LH)			S, P
	Female
		Menstruating
		Follicular phase		2.0-15.0U/L	2.0-15.0mIU/mL
		Ovulatory phase		22.0-105.0U/L	22.0-105.0mIU/mL
		Luteal phase		0.6-19.0U/L	0.6-19.0mIU/mL
		Postmenopausal		16.0-64.0U/L	16.0-64.0mIU/mL
	Male			2.0-12.0U/L	2.0-12.0mIU/mL
Magnesium			S	0.62-0.95mmol/L	1.5-2.3mg/dL
Metanephrine			P	<0.5nmol/L	<100pg/mL
Methemoglobin			WB	0.0-0.01	0-1%
Myoglobin			S
	Male			20-71μg/L	20-71μg/L
	Female			25-58μg/L	25-58μg/L
Norepinephrine			P
	Supine (30 min)			650-2,423pmol/L	110-410pg/mL
	Sitting			709-4,019pmol/L	120-680pg/mL
	Standing (30 min)			739-4,137pmol/L	125-700pg/mL
Osmolality			P	275-295 mOsmol/kg serum	275-295mOsmol/kg serum
				water	water
Osteocalcin			S	11-50μg/L	11-50ng/mL
Oxygen content			WB
	Arterial (sea level)			17-21	17-21vol%
	Venous (sea level)			10-16	10-16vol%
Oxygen saturation (sea level)			WB	Fraction:	Percent:
	Arterial			0.94-1.0	94-100%
	Venous, arm			0.60-0.85	60-85%
Parathyroid hormone (intact)			S	8-51ng/L	8-51g/mL
Phosphatase, alkaline			S	0.56-1.63μkat/L	33-96U/L
Phosphorus, inorganic			S	0.81-1.4mmol/L	2.5-4.3mg/dL
Potassium			S	3.5-5.0mmol/L	3.5-5.0meq/L
Prealbumin			S	170-340mg/L	17-34mg/dL
Procalcitonin			S	<0.1μg/L	<0.1ng/mL
Progesterone			S, P
	Female:
		Follicular		<3.18nmol/L	<1.0ng/mL
		Midluteal		9.54-63.6nmol/L	3-20ng/mL
	Male			<3.18nmol/L	<1.0ng/mL
Prolactin			S
	Male			53-360mIU/L	2.5-17ng/mL
	Female			40-530mIU/L	1.9-25ng/mL
Prostate-specific antigen (PSA)			S	0.0-4.0μg/L	0.0-4.0ng/mL
Protein fractions:			S
	Albumin			35-55g/L	3.5 -5.5g/dL (50-60%)
	Globulin			20-35g/L	2.0-3.5g/dL (40-50%)
	Alpha1			2-4g/L	0.2-0.4g/dL (4.2-7.2%)
	Alpha2			5-9g/L	0.5-0. g/dL (6.8-12%)
	Beta			6-11g/L	0.6-1.1g/dL (9.3-15%)
Gamma				7-17g/L	0.7-1.7g/dL (13-23%)
	Protein, total		S	67-86g/L	6.7-8.6g/dL
Pyruvate			P	40-130μmol/L	0.35-1.14mg/dL
Rheumatoid factor			S	<15kIU/L	<15IU/mL
Serotonin			WB	0.28-1.14umol/L	50-200ng/mL
Serum protein electrophoresis			S	Not applicable	Normal pattern
Sex hormone-binding globulin (adult			S	11-80nmol/L	11-80nmol/L
	Male			30-135nmol/L	30-135nmol/L
	Female
Sodium			S	136-146mmol/L	136-146meq/L
Testosterone, free			S
	Female, adult			10.4-65.9pmol/L	3-19pg/mL
	Male, adult			312-1041pmol/L	90-300pg/mL
Testosterone, total,			S
	Female			0.21-2.98nmol/L	6-86ng/dL
	Male			9.36-37.10nmol/L	270-1070ng/dL
Thyroglobulin			S	1.3-31.8μg/L	1.3-31.8ng/mL
Thyroid-binding globulin			S	13-30mg/L	1.3-3.0mg/dL
	Thyroid-stimulating hormone		S	0.34-4.25 mIU/L	0.34-4.25μIU/mL
	Thyroxine, free (fT4)		S	9.0-16pmol/L	0.7-1.24ng/dL
Thyroxine, total (T4)			S	70-151nmol/L	5.4-11.7μg/dL
Thyroxine index (free)			S	6.7-10.9	6.7-10.9
Transferrin			S	2.0-4.0g/L	200-400mg/dL
Triiodothyronine, free (fT3)			S	3.7-6.5pmol/L	2.4-4.2pg/mL
Triiodothyronine, total (T3)			S	1.2-2.1nmol/L	77-135ng/dL
Urea nitrogen			S	2.5-7.1mmol/L	7-20mg/dL
Uric acid			S
	Females			0.15-0.33mmol/L	2.5-5.6mg/dL
	Males			0.18-0.41mmol/L	3.1-7.0mg/dL
Vasoactive intestinal polypeptide			P	0-60ng/L	0-60 g/mL

TABLE 3. Classification of LDL, Total, and HDL Cholesterol

LDL Cholesterol
<70mg/dL	Therapeutic option for very high risk patients
<100mg/dL	Optimal
100-129mg/dL	Near optimal/above optimal
130-159mg/dL	Borderline high
160-189mg/dL	High
≥190mg/dL	Very high
Total Cholesterol
<200mg/dL	Desirable
200-239mg/dL	Borderline high
≥240mg/dL	High
HDL Cholesterol
<40mg/dL	Low
≥60mg/dL	High

TABLE 4. Urine Analysis and Renal Function Tests

		Reference Range
		SI Units	Conventional Units
Acidity, titratable		20-40mmol/d	20-40meq/d
Aldosterone
		Normal diet: 6-25μg/d	Normal diet: 6-25μg/d
		Low-salt diet: 17-44μg/d	Low-salt diet: 17-44μg/d
		High-salt diet: 0-6μg/d	High-salt diet: 0-6μg/d
Aluminum		0.19-1.11μmol/L	5-30μg/L
Ammonia		30-50mmol/d	30-50meq/d
Amylase			4-400U/L
Amylase/creatinine clearance ratio [(Clam/Clcr)×100]		1-5	1-5
Arsenic		0.07-0.67μmol/d	5-50μg/d
Bence Jones protein, urine, qualitative		None detected	None detected
Bence Jones protein, urine, quantitative
	Free Kappa	1.4-24.2mg/L	0.14-2.42mg/dL
	Free Lambda	0.2-6.7mg/L	0.02-0.67mg/dL
	K/L ratio	2.04-10.37	2.04-10.37
Calcium (10 meq/d or 200 mg/d dietary calcium		<7.5mmol/d	<300mg/d
Chloride		140-250mmol/d	140-250mmol/d
Citrate		320-1,240mg/d	320-1,240mg/d
Copper		<0.95μmol/d	<60μg/d
Coproporphyrins (types I and III)		0-20μmol/mol creatinine	0-20μmol/mol creatinine
Cortisol, free		55-193nmol/d	20-70μg/d
Creatine, as creatinine
	Female	<760μmol/d	<100mg/d
	Male	<380μmol/d	<50mg/d
Creatinine		8.8-14 mmol/d	1.0-1.6g/d
Dopamine		392-2,876nmol/d	60-440μg/d
Eosinophils		<100eosinophils/mL	<100eosinophils/mL
Epinephrine		0-109nmol/day	0-20μg/day
Glomerular filtration rate		>60mL/min/1.73 m2	>60mL/min/1.73 m2
		For African Americans	For African Americans multiply
		multiply the result by 1.21	the result by 1.21
Glucose (glucose oxidase method)		0.3-1.7mmol/d	50-300mg/d
5-Hydroindoleacetic acid [5-HIAA]		0-78.8μmol/d	0-15mg/d
Hydroxyproline		53-328μmol/d	53-328μmol/d
Ketone (acetone)		Negative	Negative
17 Ketosteroids		3-12mg/d	3-12mg/d
Metanephrines
	Metanephrine	30-350μg/d	30-350μg/d
	Normetanephrine	50-650μg/d	50-650μg/d
Microalbumin
	Normal	0.0-0.03g/d	0-30mg/d
	Microalbuminuria	0.03-0.30g/d	30-300mg/d
	Clinical albuminuria	>0.3g/d	>300mg/d
Microalbumin/creatinine ratio
	Normal	0-3.4g/mol creatinine	0-30μg/mg creatinine
	Microalbuminuria	3.4-34g/mol creatinine	30-300μg/mg creatinine
	Clinical albuminuria	>34g/mol creatinine	>300μg/mg creatinine
β2-Microglobulin		0-160μg/L	0-160μg/L
Norepinephrine		89-473nmol/d	15-80μg/d
N-telopeptide (cross-linked), NTx
	Female, premenopausal	17-94nmol BCE/mmol Cr	17-94nmol BCE/mmol Cr
	Female, postmenopausal	26-124nmol BCE/mmol Cr	26-124nmol BCE/mmol Cr
	Male	21-83nmol BCE/mmol Cr	21-83nmol BCE/mmol Cr
	BCE=bone collagen equivalent
Osmolality		500-800mOsmol/kg water	500-800mOsmol/kg water
pH		5.0-9.0	5.0-9.0
Phosphate (phosphorus) (varies with intake)		12.9-42.0mmol/d	400-1300mg/d
Porphobilinogen		None	None
Potassium (varies with intake)		25-100mmol/d	25-100meq/d
Protein		<0.15g/d	<150mg/d
Protein/creatinine ratio		Male: 15-68mg/g
Female: 10-107 mg/g		Male: 15-68mg/g
Female: 10-107 mg/g
Sediment
	Red blood cells	0-2/high-power field
	White blood cells	0-2/high-power field
	Bacteria	None
	Crystals	None
	Bladder cells	None
	Squamous cells	None
	Tubular cells	None
	Broad casts	None

TABLE 5. Body Fluids and Other Mass Data

			Reference Range
			SI Units	Conventional Units
Body fluid
	Total volume (lean) of body weight		50% (in obese) to 70%
	Intracellular		0.3-0.4 of body weight
	Extracellular		0.2-0.3 of body weight
Blood
	Total volume
		Males	69mL/kg body weight
		Females	65mL/kg body weight
	Plasma volume
		Males	39mL/kg body weight
		Females	40mL/kg body weight
	Red blood cell volume
		Males	30mL/kg body weight	1.15-1.21L/m2 of body surface area
		Females	25mL/kg body weight	0.95-1.00L/m2 of body surface area
Body mass index			18.5-24.9kg/m2	18.5-24.9kg/m2

비뇨기과 상병코드

KCD6 코드	KCD6 한글명칭	KCD6 영문명칭
A18	기타 기관의 결핵	Tuberculosis of other organs
A18.1	비뇨생식계통의 결핵	Tuberculosis of genitourinary system
A18.10	신장 및 요관의 결핵	Tuberculosis of kidney and ureter (N29.1*)
A18.11	방광의 결핵	Tuberculosis of bladder (N33.0*)
A18.12	기타 비뇨기관의 결핵	Tuberculosis of other urinary organs
A18.13	전립선의 결핵	Tuberculosis of prostate (N51.0*)
A18.14	기타 남성 생식기관의 결핵	Tuberculosis of other male genital organs (N51.-*)
A50	선천 매독	Congenital syphilis
A51	조기 매독	Early syphilis
A52	만기 매독	Late syphilis
A53	기타 및 상세불명의 매독	Other and unspecified syphilis
A54	임균감염	Gonococcal infection
A54.0	요도주위 또는 부속선에 농양이 없는 하부 비뇨생식관의 임균감염	Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess
A54.1	요도주위 및 부속선에 농양이 있는 하부 비뇨생식관의 임균감염	Gonococcal infection of lower genitourinary tract with periurethral and accessory gland abscess
A54.2	임균성 골반복막염 및 기타 임균성 비뇨생식기 감염	Gonococcal pelviperitonitis and other gonococcal genitourinary infections
A55	클라미디아 림프육아종 (성병성)	Chlamydial lymphogranuloma (venereum)
A56	기타 성행위로 전파되는 클라미디아질환	Other sexually transmitted chlamydial diseases
A56.0	하부비뇨생식관의 클라미디아감염	Chlamydial infection of lower genitourinary tract
A56.1	골반복막 및 기타 비뇨생식기관의 클라미디아 감염	Chlamydial infection of pelviperitoneum and other genitourinary organs
A56.2	상세불명의 비뇨생식관의 클라미디아감염	Chlamydial infection of genitourinary tract, unspecified
A57	무른궤양	Chancroid
A58	사타구니육아종	Granuloma inguinale
A59	편모충증	Trichomoniasis
A59.0	비뇨생식기의 편모층증	Urogenital trichomoniasis
A59.01	편모충성 전립선염	Trichomonal prostatitis (N51.0*)
A59.02	편모충성 방광염 및 요도염	Trichomonal cystitis and urethritis
A59.08	기타 및 상세불명의 비뇨생식기계 편모충증	Other and unspecified urogenital trichomoniasis
A60	항문생식기의 헤르페스바이러스 [단순헤르페스] 감염	Anogenital herpesviral [herpes simplex] infection
A60.0	생식기관 및 비뇨생식관의 헤르페스바이러스 감염	Herpesviral infection of genitalia and urogenital tract
A60.00	음경의 헤르페스바이러스감염	Herpesviral infection of penis
A60.01	기타 남성 생식기관의 헤르페스바이러스감염	Herpesviral infection of other male genital organs
A63.0	항문생식기의 (성병성) 사마귀	Anogenital (venereal) warts
B26	볼거리	Mumps
B26.0	볼거리고환염	Mumps orchitis (N51.1*)
B37.4	기타 비뇨생식기 부위의 칸디다증	Candidiasis of other urogenital sites
B37.40	칸디다방광염 및 요도염	Candidal cystitis and urethritis (N37.0*)
B37.41	칸디다귀두염	Candidal balanitis (N51.2*)
B37.48	기타 비뇨생식기 부위의 칸디다증	Other urogenital candidiasis
B85.3	사면발이증	Phthiriasis
C60	음경의 악성 신생물	Malignant neoplasm of penis
C60.0	포피의 악성 신생물	Malignant neoplasm of prepuce
C60.1	음경귀두의 악성 신생물	Malignant neoplasm of glans penis
C60.2	음경체의 악성 신생물	Malignant neoplasm of body of penis
C61	전립선의 악성 신생물	Malignant neoplasm of prostate
C62	고환의 악성 신생물	Malignant neoplasm of testis
C62.0	미하강고환의 악성 신생물	Malignant neoplasm of undescended testis
C62.1	하강고환의 악성 신생물	Malignant neoplasm of descended testis
C62.9	상세불명의 고환의 악성 신생물	Malignant neoplasm of testis, unspecified
C63	기타 및 상세불명의 남성 생식기관의 악성 신생물	Malignant neoplasm of other and unspecified male genital organs
C63.0	부고환의 악성 신생물	Malignant neoplasm of epididymis
C63.1	정삭의 악성 신생물	Malignant neoplasm of spermatic cord
C63.2	음낭의 악성 신생물	Malignant neoplasm of scrotum
C64	신우를 제외한 신장의 악성 신생물	Malignant neoplasm of kidney, except renal pelvis
C64.0	신우를 제외한 신장의 악성 신생물, 오른쪽	Malignant neoplasm of kidney, except renal pelvis, Right
C64.1	신우를 제외한 신장의 악성 신생물, 왼쪽	Malignant neoplasm of kidney, except renal pelvis, Left
C64.9	신우를 제외한 신장의 악성 신생물, 상세불명 부위	Malignant neoplasm of kidney, except renal pelvis, Unspecified side
C65	신우의 악성 신생물	Malignant neoplasm of renal pelvis
C66	요관의 악성 신생물	Malignant neoplasm of ureter
C67	방광의 악성 신생물	Malignant neoplasm of bladder
C67.0	방광삼각부의 악성 신생물	Malignant neoplasm of trigone of bladder
C67.1	방광의 둥근천장부의 악성 신생물	Malignant neoplasm of dome of bladder
C67.2	방광의 측벽의 악성 신생물	Malignant neoplasm of lateral wall of bladder
C67.3	방광의 전벽의 악성 신생물	Malignant neoplasm of anterior wall of bladder
C67.4	방광의 후벽의 악성 신생물	Malignant neoplasm of posterior wall of bladder
C67.5	방광경부의 악성 신생물	Malignant neoplasm of bladder neck
C67.6	요관구의 악성 신생물	Malignant neoplasm of ureteric orifice
C67.7	요막관의 악성 신생물	Malignant neoplasm of urachus
C67.8	방광의 중복병변의 악성 신생물	Malignant neoplasm of overlapping lesion of bladder
C67.9	상세불명의 방광의 악성 신생물	Malignant neoplasm of bladder, unspecified
C68	기타 및 상세불명의 비뇨기관의 악성 신생물	Malignant neoplasm of other and unspecified urinary organs
C68.0	요도의 악성 신생물	Malignant neoplasm of urethra
C68.1	요도주위샘의 악성 신생물	Malignant neoplasm of paraurethral gland
C68.8	비뇨기관의 중복병변의 악성 신생물	Malignant neoplasm of overlapping lesion of urinary organs
C68.9	상세불명의 비뇨기관의 악성 신생물	Malignant neoplasm of urinary organ, unspecified
C74	부신의 악성 신생물	Malignant neoplasm of adrenal gland
C74.0	부신피질의 악성 신생물	Malignant neoplasm of cortex of adrenal gland
C74.1	부신수질의 악성 신생물	Malignant neoplasm of medulla of adrenal gland
C74.9	상세불명의 부신의 악성 신생물	Malignant neoplasm of adrenal gland, unspecified
C79	기타 및 상세불명 부위의 이차성 악성 신생물	Secondary malignant neoplasm of other sites
C79.0	신장 및 신우의 이차성 악성 신생물	Secondary malignant neoplasm of kidney and renal pelvis
C79.00	신장 및 신우의 이차성 악성 신생물, 오른쪽	Secondary malignant neoplasm of kidney and renal pelvis, Right
C79.01	신장 및 신우의 이차성 악성 신생물, 왼쪽	Secondary malignant neoplasm of kidney and renal pelvis, Left
C79.09	신장 및 신우의 이차성 악성 신생물, 상세불명 부위	Secondary malignant neoplasm of kidney and renal pelvis, Unepecified side
C79.1	방광 및 기타 상세불명의 비뇨기관의 이차성 악성 신생물	Secondary malignant neoplasm of bladder and other and unspecified urinary organs
C79.10	방광의 이차성 악성 신생물	Secondary malignant neoplasm of bladder
C79.18	기타 및 상세불명 비뇨기관의 이차성 악성 신생물	Secondary malignant neoplasm of other and unspecified urinary organs
D07.4	음경의 제자리암종	Carcinoma in situ of penis
D07.5	전립선의 제자리암종	Carcinoma in situ of prostate
D07.6	기타 및 상세불명의 남성 생식기관의 제자리암종	Carcinoma in situ of other and unspecified male genital organs
D09.0	방광의 제자리암종	Carcinoma in situ of bladder
D09.1	기타 및 상세불명의 비뇨기관의 제자리암종	Carcinoma in situ of other and unspecified urinary organs
D17.6	정삭의 양성 지방종성 신생물	Benign lipomatous neoplasm of spermatic cord
D20	후복막 및 복막 연조직의 양성 신생물	Benign neoplasm of soft tissue of retroperitoneum and peritoneum
D20.0	후복막의 양성 신생물	Benign neoplasm of retroperitoneum
D29	남성 생식기관의 양성 신생물	Benign neoplasm of male genital organs
D29.0	음경의 양성 신생물	Benign neoplasms of penis
D29.1	전립선의 양성 신생물	Benign neoplasms of prostate
D29.2	고환의 양성 신생물	Benign neoplasms of testis
D29.3	부고환의 양성 신생물	Benign neoplasms of epididymis
D29.4	음낭의 양성 신생물	Benign neoplasms of scrotum
D29.7	기타 남성 생식기관의 양성 신생물	Benign neoplasms of other male genital organ
D29.9	상세불명의 남성 생식기관의 양성 신생물	Benign neoplasms of male genital organ, unspecified
D30	비뇨기관의 양성 신생물	Benign neoplasm of urinary organs
D30.0	신장의 양성 신생물	Benign neoplasm of kidney
D30.00	신장의 양성 신생물, 오른쪽	Benign neoplasm of kidney, right
D30.01	신장의 양성 신생물, 왼쪽	Benign neoplasm of kidney, left
D30.09	신장의 양성 신생물, 상세불명 부위	Benign neoplasm of kidney, unspecified side
D30.1	신우의 양성 신생물	Benign neoplasm of renal pelvis
D30.2	요관의 양성 신생물	Benign neoplasm of ureter
D30.3	방광의 양성 신생물	Benign neoplasm of bladder
D30.4	요도의 양성 신생물	Benign neoplasm of urethra
D30.7	기타 비뇨기관의 양성 신생물	Benign neoplasm of other urinary organs
D30.9	상세불명의 비뇨기관의 양성 신생물	Benign neoplasm of urinary organ, unspecified
D40	남성 생식기관의 행동양식 불명 또는 미상의 신생물	Neoplasm of uncertain or unknown behavior of male genital organs
D40.0	전립선의 행동양식 불명 또는 미상의 신생물	Neoplasm of uncertain or unknown behavior of prostate
D40.1	고환의 행동양식 불명 또는 미상의 신생물	Neoplasm of uncertain or unknown behavior of testis
D40.7	기타 남성 생식기관의 행동양식 불명 또는 미상의 신생물	Neoplasm of uncertain or unknown behavior of other male genital organs
D40.9	상세불명의 남성 생식기관의 행동양식 불명 또는 미상의 신생물	Neoplasm of uncertain or unknown behavior of male genital organ, unspecified
D41	비뇨기관의 행동양식 불명 또는 미상의 신생물	Neoplasm of uncertain or unknown behavior of urinary organs
D41.0	신장의 행동양식 불명 또는 미상의 신생물	Neoplasm of uncertain or unknown behavior of kidney
D41.00	신장의 행동양식 불명 또는 미상의 신생물, 오른쪽	Neoplasm of uncertain or unknown behavior of kidney, right
D41.01	신장의 행동양식 불명 또는 미상의 신생물, 왼쪽	Neoplasm of uncertain or unknown behavior of kidney, left
D41.09	신장의 행동양식 불명 또는 미상의 신생물, 상세불명 부위	Neoplasm of uncertain or unknown behavior of kidney, unspecified side
D41.1	신우의 행동양식 불명 또는 미상의 신생물	Neoplasm of uncertain or unknown behavior of renal pelvis
D41.2	요관의 행동양식 불명 또는 미상의 신생물	Neoplasm of uncertain or unknown behavior of ureter
D41.3	요도의 행동양식 불명 또는 미상의 신생물	Neoplasm of uncertain or unknown behavior of urethra
D41.4	방광의 행동양식 불명 또는 미상의 신생물	Neoplasm of uncertain or unknown behavior of bladder
D41.7	기타 비뇨기관의 행동양식 불명 또는 미상의 신생물	Neoplasm of uncertain or unknown behavior of other urinary organs
D41.9	상세불명의 비뇨기관의 행동양식 불명 또는 미상의 신생물	Neoplasm of uncertain or unknown behavior of urinary organ, unspecified
E29	고환의 기능이상	Testicular dysfunction
E29.0	고환 과도기능	Testicular hyperfunction
E29.1	고환 기능저하	Testicular hypofunction
E29.8	기타 고환기능이상	Other testicular dysfunction
E29.9	상세불명의 고환기능 이상	Testicular dysfunction, unspecified
N11.0	비폐색성 역류-연관 만성 신우신염	Nonobstructive refluxassociated chronic pyelonephritis
N11.1	만성 폐색성 신우신염	Chronic obstructive pyelonephritis
N13	폐색성 및 역류성 요로병증	Obstructive and reflux uropathy
N13.0	요관신우 이행부 폐색을 동반한 수신증	Hydronephrosis with ureteropelvic junction obstruction
N13.1	달리 분류되지 않은 요관 협착을 동반한 수신증	Hydronephrosis with ureteral stricture, NEC
N13.2	신장 및 요관 결석성 폐색을 동반한 수신증	Hydronephrosis with renal and ureteral calculous obstruction
N13.3	기타 및 상세불명의 수신증	Other and unspecified hydronephrosis
N13.38	기타 수신증	Other hydronephrosis
N13.39	상세불명의 수신증	Unspecified hydronephrosis
N13.4	수뇨관증	Hydroureter
N13.5	수신증을 동반하지 않은 요관의 꼬임 및 협착	Kinking and stricture of ureter without hydronephrosis
N13.6	농신증	Pyonephrosis
N13.7	방광요관 역류와 관련된 요로병증	Vesicoureteral-refluxassociated uropathy
N13.70	역류신장병증을 동반하지 않은 방광요관 역류와 관련된 요로병증	Vesicoureteral-refluxassociated uropathy, without reflux nephropathy
N13.71	역류신장병증을 동반한, 수뇨관증을 동반하지 않은 방광요관 역류와 관련된 요로병증	Vesicoureteral-refluxassociated uropathy, with reflux nephropathy, without hydroureter
N13.72	역류신장병증을 동반한, 수뇨관증을 동반한 방광 요관 역류와 관련된 요로병증	Vesicoureteral-refluxassociated uropathy, with reflux nephropathy, with hydroureter
N13.79	방광요관역류와 관련된 상세불명의 요로병증	Vesicoureteral-refluxassociated uropathy, unspecified
N13.8	기타 폐색성 및 역류성 요로병증	Other obstructive and reflux uropathy
N13.9	상세불명의 폐색성 및 역류성 요로병증	Obstructive and reflux uropathy, unspecified
N17	급성 신부전	Acute renal failure
N17.0	세뇨관 괴사를 동반한 급성 신부전	Acute renal failure with tubular necrosis
N17.1	급성 피질 괴사를 동반한 급성 신부전	Acute renal failure with acute cortical necrosis
N17.2	수질 괴사를 동반한 급성 신부전	Acute renal failure with medullary necrosis
N17.8	기타 급성 신부전	Other acute renal failure
N17.9	상세불명의 급성 신부전	Acute renal failure, unspecified
N18	만성 신장질환	Chronic kidney disease
N18.9	상세불명의 만성 신장질환	Chronic kidney disease, unspecified
N19	상세불명의 신부전	Unspecified renal failure
N20	신장 및 요관의 결석	Calculus of kidney and ureter
N20.0	신장의 결석	Calculus of kidney
N20.1	요관의 결석	Calculus of ureter
N20.2	요관결석을 동반한 신장결석	Calculus of kidney with calculus of ureter
N20.9	상세불명의 신장결석	Urinary calculus, unspecified
N21	하부 요로의 결석	Calculus of lower urinary tract
N21.0	방광의 결석	Calculus in bladder
N21.1	요도 결석	Calculus in urethra
N21.8	기타 하부 요로 결석	Other lower urinary tract calculus
N21.9	상세불명의 하부 요로 결석	Calculus of lower urinary tract, unspecified
N22	달리 분류된 질환에서의 요로의 결석	Calculus of urinary tract in diseases classified elsewhere
N22.0	주혈흡충증에서의 요결석 [빌하르츠 주혈 흡충증]	Urinary calculus in schistosomiasis [bilharziasis](B65.-+)
N22.8	달리 분류된 기타 질환에 서의 요로의 결석	Calculus of urinary tract in other diseases classified elsewhere
N23	상세불명의 신장 급통증	Unspecified renal colic
N25.1	신장성 요붕증	Nephrogenic diabetes insipidus
N26	상세불명의 신장위축	Unspecified contracted kidney
N27	원인미상의 작은 신장	Small kidney of unknown cause
N27.0	한쪽 작은 신장	Small kidney, unilateral
N27.1	양쪽 작은 신장	Small kidney, bilateral
N27.9	상세불명의 작은 신장	Small kidney, unspecified
N28	달리 분류되지 않은 신장 및 요관의 기타 장애	Other disorders of kidney and ureter, NEC
N28.0	신장의 허혈 및 경색증	Ischemia and infarction of kidney
N28.1	후천성 신장의 낭	Cyst of kidney, acquired
N28.8	기타 명시된 신장 및 요관의 장애	Other specified disorders of kidney and ureter
N28.80	신장의 비대	Hypertrophy of kidney
N28.81	거대요관	Megaloureter
N28.82	신장하수	Nephroptosis
N28.83	낭성 신우염	Cystica pyelitis
N28.84	낭성 신우요관염	Cystica pyeloureteritis
N28.85	낭성 요관염	Cystica ureteritis
N28.88	기타 명시된 신장 및 요관의 장애	Other specified disorders of kidney and ureter
N28.9	상세불명의 신장 및 요관장애	Disorder of kidney and ureter, unspecified
N29	달리 분류된 질환에서의 신장 및 요관의 기타장애	Other disorders of kidney and ureter in diseases classified elsewhere
N29.0	신장의 만기매독	Late syphilis of kidney (A52.7+)
N29.1	달리 분류된 감염성 및 기생충성 질환에서의 신장 및 요관의 기타 장애	Other disorders of kidney and ureter in infectious and parasitic diseases classified elsewhere
N29.8	달리 분류된 기타 질환에서의 신장 및 요관의 기타 장애	Other disorders of kidney and ureter in diseases classified elsewhere
N30	방광염	Cystitis
N30.0	급성 방광염	Acute cystitis
N30.1	간질방광염 (만성)	Interstitial cystitis (chronic)
N30.2	기타 만성 방광염	Other chronic cystitis
N30.3	삼각부염	Trigonitis
N30.4	방사선 방광염	Irradiation cystitis
N30.8	기타 방광염	Other cystitis
N30.9	상세불명의 방광염	Cystitis, unspecified
N31	달리 분류되지 않은 방광의 신경근육 기능 장애	Neuromuscular dysfunction of bladder, NEC
N31.0	달리 분류되지 않은 비억제성 신경병성 방광	Uninhibited neuropathic bladder, NEC
N31.1	달리 분류되지 않은 반사성 신경병성 방광	Reflex neuropathic bladder, NEC
N31.2	달리 분류되지 않은 이완성 신경병성 방광	Flaccid neuropathic bladder, NEC
N31.8	기타 방광의 신경근육 기능장애	Other neuromuscular dysfunction of bladder
N31.9	상세불명의 방광의 신경근육기능장애	Neuromuscular dysfunction of bladder, unspecified
N32	방광의 기타 장애	Other disorders of bladder
N32.0	방광-목 폐색	Bladder-neck obstruction
N32.1	방광장누공	Vesicointestinal fistula
N32.2	달리 분류되지 않은 방광누공	Vesical fistula, NEC
N32.3	방광의 게실	Diverticulum of bladder
N32.4	비외상성 방광 파열	Rupture of bladder, nontraumatic
N32.8	기타 명시된 방광의 장애	Other disorders of bladder
N32.9	상세불명의 방광 장애	Bladder disorder, unspecified
N33	달리 분류된 질환에서의 방광 장애	Bladder disorders in diseases classified elsewhere
N33.0	결핵성 방광염	Tuberculous cystitis (A18.1+)
N33.8	달리 분류된 기타 질환에서의 방광 장애	Bladder disorder in other diseases classified elsewhere
N34	요도염 및 요도 증후군	Urethritis and urethral syndrome
N34.0	요도농양	Urethral abscess
N34.1	비특이성 요도염	Nonspecific urethritis
N34.2	기타 요도염	Other urethritis
N34.3	상세불명의 요도 증후군	Urethral syndrome, unspecified
N35	요도 협착	Urethral stricture
N35.0	외상후 요도 협착	Post-traumatic urethral stricture
N35.1	달리 분류되지 않은 감염 후 요도 협착	Postinfective urethral stricture, NEC
N35.8	기타 요도 협착	Other urethral stricture
N35.9	상세불명의 요도 협착	Urethral stricture, unspecified
N36	요도의 기타 장애	Other disorders of urethra
N36.0	요도누공	Urethral fistula
N36.1	요도게실	Urethral diverticulum
N36.2	요도카룬클	Urethral caruncle
N36.3	탈출된 요도점막	Prolapsed urethral mucosa
N36.8	기타 명시된 요도장애	Other specified disorders of urethra
N36.9	상세불명의 요도장애	Urethral disorder, unspecified
N37	달리 분류된 질환에서의 요도장애	Urethral disorders in diseases classified elsewhere
N37.0	달리 분류된 질환에서의 요도염	Urethritis in diseases classified elsewhere
N37.8	달리 분류된 질환에서의 기타 요도장애	Other urethral disorders in diseases classified elsewhere
N39	비뇨계통의 기타 장애	Other disorders of urinary system
N39.0	부위가 명시되지 않은 요로 감염	Urinary tract infection, site not specified
N39.1	상세불명의 지속성 단백뇨	Persistent proteinuria, unspecified
N39.2	상세불명의 기립성 단백뇨	Orthostatic proteinuria, unspecified
N39.3	스트레스요실금	Stress incontinence
N39.4	기타 명시된 요실금	Other specified urinary incontinence
N39.40	절박 요실금	Urge incontinence
N39.41	혼합 요실금	Mixed incontinence
N39.48	기타 명시된 요실금	Other specified urinary incontinence
N39.8	기타 명시된 비뇨계통의 장애	Other specified disorders of urinary system
N39.9	상세불명의 비뇨계통 장애	Disorder of urinary system, unspecified
N40	전립선의 증식증	Hyperplasia of prostate
N40.0	합병증을 동반하지 않은 전립선의 증식증	Hyperplasia of prostate without complication
N40.1	폐색을 동반한 전립선의 증식증	Hyperplasia of prostate with obstruction
N40.2	혈뇨를 동반한 전립선의 증식증	Hyperplasia of prostate with hematuria
N40.3	폐색 및 혈뇨를 동반한 전립선의 증식증	Hyperplasia of prostate with obstruction and hematuria
N40.8	기타 합병증을 동반한 전립선의 증식증	Hyperplasia of prostate with other complication
N41	전립선의 염증성 질환	Inflammatory diseases of prostate
N41.0	급성 전립선염	Acute prostatitis
N41.00	혈뇨를 동반하지 않은 급성 전립선염	Acute prostatitis, without hematuria
N41.01	혈뇨를 동반한 급성 전립선염	Acute prostatitis, with hematuria
N41.1	만성 전립선염	Chronic prostatitis
N41.10	혈뇨를 동반하지 않은 만성 전립선염	Chronic prostatitis, without hematuria
N41.11	혈뇨를 동반한 만성 전립선염	Chronic prostatitis, with hematuria
N41.2	전립선의 농양	Abscess of prostate
N41.3	전립선방광염	Prostatocystitis
N41.8	기타 전립선의 염증성 질환	Other inflammatory diseases of prostate
N41.80	육아종 전립선염	Granulomatous prostatitis
N41.88	기타 전립선염	Other prostatitis
N41.9	상세불명의 전립선의 염증성 질환	Inflammatory disease of prostate, unspecified
N42	전립선의 기타 장애	Other disorders of prostate
N42.0	전립선의 결석	Calculus of prostate
N42.1	전립선의 울혈 및 출혈	Congestion and hemorrhage of prostate
N42.2	전립선의 위축	Atrophy of prostate
N42.3	전립선의 이형성	Dysplasia of prostate
N42.8	기타 명시된 전립선의 장애	Other specified disorders of prostate
N42.9	상세불명의 전립선의 장애	Disorder of prostate, unspecified
N43	음낭수류 및 정액류	Hydrocele and spermatocele
N43.0	피낭성 음낭수류	Encysted hydrocele
N43.1	감염성 음낭수류	Infected hydrocele
N43.2	기타 음낭수류	Other hydrocele
N43.3	상세불명의 음낭수류	Hydrocele, unspecified
N43.4	정액류	Spermatocele
N44	고환의 염전	Torsion of testis
N45	고환염 및 부고환염	Orchitis and epididymitis
N45.0	농양을 동반한 고환염, 부고환염 및 부고환고환염	Orchitis, epididymitis and epididymo-orchitis with abscess
N45.00	농양을 동반한 부고환염	Epididymitis, with abscess
N45.01	농양을 동반한 고환염	Orchitis, with abscess
N45.02	농양을 동반한 부고환고환염	Epididymo-orchitis, with abscess
N45.9	농양을 동반하지 않은 고 환염, 부고환염 및 부고 환-고환염	Orchitis, epididymitis and epididymo-orchitis without abscess
N45.90	농양을 동반하지 않은 부고환염	Epididymitis, without abscess
N45.91	농양을 동반하지 않은 고환염	Orchitis, without abscess
N45.92	농양을 동반하지 않은 부고환-고환염	Epididymo-orchitis, without abscess
N46	남성 불임	Male infertility
N47	과잉포피, 포경 및 감돈 포경	Redundant prepuce, phimosis and paraphimosis
N48	음경의 기타 장애	Other disorders of penis
N48.0	음경의 백반증	Leukoplakia of penis
N48.1	귀두포피염	Balanoposthitis
N48.2	음경의 기타 염증성 장애	Other inflammatory disorders of penis
N48.20	음경의 농양	Abscess of penis
N48.21	음경의 연조직염	Cellulitis of corpus cavernosum and penis
N48.28	음경의 기타 염증성 장애	Other imflammatory disorder of penis
N48.3	지속발기증	Priapism
N48.4	기질적 원인에 의한 발기불능	Impotence of organic origin
N48.40	동맥기능부전에 의한 남성 발기장애	Male erectile dysfunction due to arteral insufficiency
N48.41	해면체폐쇄부전으로 인한 남성 발기장애	Male erectile dysfunction due to corporovenous occlusive dysfunction
N48.48	기타 원인으로 인한 남성 발기장애	Male erectile dysfunction due to other cause
N48.49	상세불명의 남성 발기장애	Male erectile dysfunction, unspecified
N48.5	음경의 궤양	Ulcer of penis
N48.6	성형성 음경 경화 (페니스 플라스티카)	Induratio penis plastica
N48.60	페이로니 병	Peyronie’s disease
N48.68	기타 성형성 음경경화	Plastic induration of penis
N48.8	기타 명시된 음경의 장애	Other specified disorders of penis
N48.9	상세불명의 음경의 장애	Disorder of penis, unspecified
N49	달리 분류되지 않은 남성생식기관의 염증성 장애	Inflammatory disorders of male genital organs, NEC
N49.0	정낭의 염증성 장애	Inflammatory disorders of seminal vesicle
N49.1	정삭, 초막 및 정관의 염증성 장애	Inflammatory disorders of spermatic cord, tunica vaginalis and vas deferens
N49.2	음낭의 염증성 장애	Inflammatory disorders of scrotum
N49.8	기타 명시된 남성 생식기관의 염증성 장애	Inflammatory disorders of other specified male genital organs
N49.9	상세불명의 남성 생식기관의 염증성 장애	Inflammatory disorder of unspecified male genital organ
N50	남성 생식기관의 기타 장애	Other disorders of male genital organs
N50.0	고환의 위축	Atrophy of testis
N50.1	남성 생식기관의 혈관 장애	Vascular disorders of male genital organs
N50.8	기타 명시된 남성 생식기관의 장애	Other specified disorders of male genital organs
N50.9	상세불명의 남성 생식기관의 장애	Disorder of male genital organs, unspecified
N51	달리 분류된 질환에서의 남성 생식기관의 장애	Disorders of male genital organs in diseases classified elsewhere
N51.0	달리 분류된 질환에서의 전립선장애	Disorders of prostate in diseases classified elsewhere
N51.1	달리 분류된 질환에서의 고환 및 부고환의 장애	Disorders of testis and epididymis in diseases classified elsewhere
N51.2	달리 분류된 질환에서의 귀두염	Balanitis in diseases classified elsewhere
N51.8	기타 달리 분류된 질환에서의 남성 생식기관의 장애	Other disorders of male genital organs in diseases classified elsewhere
N81	여성 생식기 탈출	Female genital prolapse
N81.0	여성 요도류	Female urethrocele
N81.1	방광류	Female cystocele
N81.2	불완전 자궁질 탈출	Incomplete uterovaginal prolapse
N81.3	완전 자궁질 탈출	Complete uterovaginal prolapse
N81.4	상세불명의 자궁질 탈출	Uterovaginal prolapse, unspecified
N81.5	질 탈장	Vaginal enterocele
N81.6	여성직장류	Female rectocele
N81.8	기타 여성 생식기 탈출	Other female genital prolapse
N81.9	상세불명의 여성 생식기 탈출	Female genital prolapse, unspecified
N82	여성 생식기를 포함한 누공	Fistulae involving female genital tract
N82.0	방광질누공	Vesicovaginal fistula
N82.1	기타 여성 비뇨-생식관 누공	Other female urinarygenital tract fistula
N99	달리 분류되지 않은 비뇨생식계통의 처치후 장애	Postprocedural disorders of genitourinary system, NEC
N99.0	처치후 신부전	Postprocedural renal failure
N99.1	처치후 요도협착	Postprocedural urethral stricture
N99.5	요로의 외부스토마의 기능부전	Malfunction of external stoma of urinary tract
N99.8	기타 비뇨생식계통의 처치후장애	Other postprocedural disorders of genitourinary system
N99.9	상세불명의 비뇨생식계통의 처치후장애	Postprocedural disorder of genitourinary system, unspecified
O71	기타 산과적 외상	Other obstetric trauma
O71.5	골반 기관에 대한 기타 산과적 손상	Other obstetric injury to pelvic organs
P39.3	신생아 요로감염	Neonatal urinary tract infection
Q05	이분척추	Spina bifida
Q05.0	수두증을 동반한 이분경추	Cervical spina bifida with hydrocephalus
Q05.1	수두증을 동반한 이분흉추	Thoracic spina bifida with hydrocephalus
Q05.2	수두증을 동반한 이분요추	Lumbar spina bifida with hydrocephalus
Q05.3	수두증을 동반한 이분천추	Sacral spina bifida with hydrocephalus
Q05.4	수두증을 동반한 상세불 명의 이분척추	Unspecified spina bifida with hydrocephalus
Q05.5	수두증이 없는 이분경추	Cervical spina bifida without hydrocephalus
Q05.6	수두증이 없는 이분흉추	Thoracic spina bifida without hydrocephalus
Q05.7	수두증이 없는 이분요추	Lumbar spina bifida without hydrocephalus
Q05.8	수두증이 없는 이분천추	Sacral spina bifida without hydrocephalus
Q05.9	상세불명의 이분척추	Spina bifida, unspecified
Q53	미하강고환	Undescended testicle
Q53.0	이소고환	Ectopic testis
Q53.1	한쪽 미하강고환	Undescended testicle, unilatera
Q53.2	양쪽 미하강고환	Undescended testicle, bilateral
Q53.9	상세불명의 미하강고환	Undescended testicle, unspecified
Q54	요도하열	Hypospadias
Q54.0	귀두부 요도하열	Hypospadias, balanic
Q54.1	음경부 요도하열	Hypospadias, penile
Q54.2	음경음낭부 요도하열	Hypospadias, penoscrotal
Q54.3	회음부 요도하열	Hypospadias, perineal
Q54.4	선천성 음경굽음	Congenital chordee
Q54.8	기타 요도하열	Other hypospadias
Q54.9	상세불명의 요도하열	Hypospadias, unspecified
Q55	남성 생식기관의 기타 선천기형	Other congenital malformations of male genital organs
Q55.0	고환의 결여 및 무형성	Absence and aplasia of testis
Q55.1	고환 및 음낭의 형성저하	Hypoplasia of testis and scrotum
Q55.2	고환 및 음낭의 기타 선천기형	Other congenital malformations of testis and scrotum
Q55.3	정관의폐쇄	Atresia of vas deferens
Q55.4	정관, 부고환, 정낭 및 전립선의 기타 선천기형	Other congenital malformations of vas deferens, epididymis, seminal vesicles and prostate
Q55.5	음경의 선천결여 및 무형성	Congenital absence and aplasia of penis
Q55.6	음경의 기타 선천기형	Other congenital malformations of penis
Q55.8	기타 명시된 남성 생식기관의 선천기형	Other specified congenital malformations of male genital organs
Q55.9	상세불명의 남성 생식기관의 선천기형	Congenital malformation of male genital organ, unspecified
Q56	불확정성 및 거짓반음양증	Indeterminate sex and pseudohermaphroditism
Q56.0	달리 분류되지 않은 반음양증	Hermaphroditism, NEC
Q56.1	달리 분류되지 않은 남성 거짓반음양증	Male pseudohermaphroditism, NEC
Q56.2	달리 분류되지 않은 여성 거짓반음양증	Female pseudohermaphroditism, NEC
Q56.3	상세불명의 거짓반음양증	Pseudohermaphroditism, unspecified
Q56.4	상세불명의 불확정성	Indeterminate sex, unspecified
Q60	신장무발생증 및 기타 감소결손	Renal agenesis and other reduction defects of kidney
Q60.0	한쪽 신장무발생증	Renal agenesis, unilateral
Q60.1	양쪽 신장무발생증	Renal agenesis, bilateral
Q60.2	상세불명의 신장무발생증	Renal agenesis, unspecified
Q60.3	한쪽 신장형성저하	Renal hypoplasia, unilateral
Q60.4	양쪽 신장형성저하	Renal hypoplasia, bilateral
Q60.5	상세불명의 신장형성저하	Renal hypoplasia, unspecified
Q60.6	포터증후군	Potter’s syndrome
Q61	낭성 신장질환	Cystic kidney disease
Q61.0	선천성 단일신장낭	Congenital single renal cyst
Q61.1	보통염색체열성의 다낭신	Polycystic kidney, autosomal recessive
Q61.2	보통염색체우성의 다낭신	Polycystic kidney, autosomal dominant
Q61.3	상세불명의 다낭신장	Polycystic kidney, unspecified
Q61.4	신장형성이상	Renal dysplasia
Q61.5	수질낭성 신장	Medullary cystic kidney
Q61.8	기타 낭성 신장질환	Other cystic kidney diseases
Q61.9	상세불명의 낭성 신장병	Cystic kidney disease, unspecified
Q62	신우의 선천성 폐색성 결손 및 요관의 선천기형	Congenital obstructive defects of renal pelvis and congenital malformations of ureter
Q62.0	선천 수신증	Congenital hydronephrosis
Q62.1	요관의 폐쇄 및 협착	Atresia and stenosis of ureter
Q62.2	선천성 거대요관	Congenital megaloureter
Q62.3	신우 및 요관의 기타 폐색성 결손	Other obstructive defects of renal pelvis and ureter
Q62.4	요관의 무발생증	Agenesis of ureter
Q62.5	요관의 중복	Duplication of ureter
Q62.6	요관의 위치이상	Malposition of ureter
Q62.7	선천성 방광-요관-신장 역류	Congenital vesico-ureterorenal reflux
Q62.8	요관의 기타 선천기형	Other congenital malformations of ureter
Q63	신장의 기타 선천기형	Other congenital malformations of kidney
Q63.0	부신장	Accessory kidney
Q63.1	분엽성, 융합성 및 말굽형신장	Lobulated, fused and horseshoe kidney
Q63.2	이소신장	Ectopic kidney
Q63.3	증식성 및 거대 신장	Hyperplastic and giant kidney
Q63.8	신장의 기타 명시된 선천 기형	Other specified congenital malformations of kidney
Q63.9	상세불명의 신장의 선천 기형	Congenital malformation of kidney, unspecified
Q64	비뇨계통의 기타 선천 기형	Other congenital malformations of urinary system
Q64.0	요도상열	Epispadias
Q64.1	방광 외반	Exstrophy of urinary bladder
Q64.2	선천성 후부요도판막	Congenital posterior urethral valves
Q64.3	요도 및 방광경부의 기타 폐쇄 및 협착	Other atresia and stenosis of urethra and bladder neck
Q64.4	요막관의 기형	Malformation of urachus
Q64.5	방광 및 요도의 선천결여	Congenital absence of bladder and urethra
Q64.6	방광의 선천게실	Congenital diverticulum of bladder
Q64.7	선천성 방광 및 요도의 기타 선천기형	Other congenital malformations of bladder and urethra
Q64.8	기타 명시된 비뇨계통의 선천기형	Other specified congenital malformations of urinary system
Q64.9	상세불명의 비뇨계통의 선천기형	Congenital malformation of urinary system, unspecified
Q98	달리 분류되지 않은 남성의 표현형의 기타 성염색 체이상	Other sex chromosome abnormalities, male phenotype, NEC
Q98.0	클라인펠터 증후군, 핵형 47, XXY	Klinefelter’s syndrome karyotype 47, XXY
Q98.1	클라인펠터 증후군, 두개 이상의 X 염색체를 가진 남성	Klinefelter’s syndrome, male with more than two X chromosomes
Q98.2	클라인펠터 증후군, 핵형 46, XX를 가진 남성	Klinefelter’s syndrome, male with 46, XX karyotype
Q98.3	핵형 46, XX를 가진 기타 남성	Other male with 46, XX karyotype
Q98.4	상세불명의 클라인펠터 증후군	Klinefelter’s syndrome, unspecified
Q98.5	핵형 47, XYY	Karyotype 47, XYY
Q98.6	구조적 이상 성염색체룰 가진 남성	Male with structurally abnormal sex chromosome
Q98.7	성염색체 섞임증을 가진 남성	Male with sex chromosome mosaicism
Q98.8	기타 명시된 남성표현형 성염색체이상	Other specified sex chromosome abnormalities, male phenotype
Q98.9	상세불명의 남성표현형 성염색체이상	Sex chromosome abnormality, male phenotype, unspecified
Q99	달리 분류되지 않은 기타 염색체이상	Other chromosome abnormalities, NEC
Q99.0	키메라46, XX/46, XY	Chimera 46, XX/46, XY
Q99.1	46, XX 진성 반음양	46, XX true hermaphrodite
R30	배뇨와 연관된 통증	Pain associated with micturition
R30.0	배뇨곤란	Dysuria
R30.1	방광 뒤무직	Vesical tenesmus
R30.9	상세불명의 배뇨통	Painful micturition, unspecified
R31	상세불명의 혈뇨	Unspecified hematuria
R31.0	육안적 혈뇨	Gross hematuria
R31.1	현미경적 혈뇨	Microscopic hematuria
R31.8	기타 및 상세불명의 혈뇨	Other and unspecified hematuria
R32	상세불명의 요실금	Unspecified urinary incontinence
R33	소변정체	Retention of urine
R34	무뇨 및 핍뇨	Anuria and oliguria
R35	다뇨	Polyuria
R36	요도 분비물	Urethral discharge
R39	기타 비뇨계통을 침습한 증상 및 징후	Other symptoms and signs involving the urinary system
R39.0	요유출	Extravasation of urine
R39.1	기타 배뇨 곤란	Other difficulties with micturition
R39.2	신장외성 요독증	Extrarenal uremia
R39.8	기타 및 상세불명의 비뇨계통을 침습한 증상 및 징후	Other and unspecified symptoms and signs involving the urinary system
R82	요의 기타 이상소견	Other abnormal findings in urine
R82.0	유미뇨	Chyluria
R82.1	마이오글로빈뇨	Myoglobinuria
R82.2	담즙뇨	Biliuria
R82.3	헤모글로빈뇨	Hemoglobinuria
R82.4	아세톤뇨	Acetonuria
S30	복부, 아래등 및 골반의 표재성 손상	Superficial injury of abdomen, lower back and pelvis
S30.0	아래등 및 골반의 타박상	Contusion of lower back and pelvis
S30.1	복벽의 타박상	Contusion of abdominal wall
S30.2	외부생식기관의 타박상	Contusion of external genital organs
S30.7	복부 아래등 및 골반의 다발성 표재성 손상	Multiple superficial injuries of abdomen, lower back and pelvis
S31	복부, 아래등 및 골반의 열린 상처	Open wound of abdomen, lower back and pelvis
S31.0	아래등 및 골반의 열린 상처	Open wound of lower back and pelvis
S31.1	복벽의 열린 상처	Open wound of abdominal wall
S31.2	음경의 열린 상처	Open wound of penis
S31.3	음낭 및 고환의 열린 상처	Open wound of scrotum and testes
S31.4	질 및 외음부의 열린 상처	Open wound of vagina and vulva
S31.5	기타 및 상세불명의 외부 생식기관의 열린 상처	Open wound of other and unspecified external genital organs
S31.7	복부, 아래등 및 골반의 다발성 열린 상처	Multiple open wounds of other abdomen, lower back and pelvis
S31.8	기타 및 상세불명의 복부 부분의 열린 상처	Open wound of other and unspecified parts of abdomen
S35.4	신장혈관의 손상	Injury of renal blood vessels
S37	비뇨 및 골반 기관의 손상	Injury of urinary and pelvic organs
S37.0	신장의 손상	Injury of kidney
S37.00	강내로의 열린 상처가 없는 신장의 손상	Injury of kidney, without open wound into cavity
S37.01	강내로의 열린 상처가 있는 신장의 손상	Injury of kidney, with open wound into cavity
S37.1	요관의 손상	Injury of ureter
S37.10	강내로의 열린 상처가 없는 요관의 손상	Injury of ureter, without open wound into cavity
S37.11	강내로의 열린 상처가 있는 요관의 손상	Injury of ureter, with open wound into cavity
S37.2	방광의 손상	Injury of bladder
S37.20	강내로의 열린 상처가 없는 방광의 손상	Injury of bladder, without open wound into cavity
S37.21	강내로의 열린 상처가 있는 방광의 손상	Injury of bladder, with open wound into cavity
S37.3	요도의 손상	Injury of urethra
S37.30	강내로의 열린 상처가 없는 요도의 손상	Injury of urethra, without open wound into cavity
S37.31	강내로의 열린 상처가 있는 요도의 손상	Injury of urethra, with open wound into cavity
S37.8	기타 골반기관의 손상	Injury of other pelvic organs
S37.80	강내로의 열린 상처가 없는 기타 골반기관의 손상	Injury of other pelvic organs, without open wound into cavity
S37.81	강내로의 열린 상처가 있 는 기타 골반기관의 손상	Injury of other pelvic organs, with open wound into cavity
S38.0	외부 생식기관의 으깸 손상	Crushing injury of external genital organs
S38.2	외부생식기관의 외상성 절단	Traumatic amputation of external genital organs
T19	비뇨생식관의 이물	Foreign body in genitourinary tract
T19.0	요도의 이물	Foreign body in urethra
T19.1	방광의 이물	Foreign body in bladder
T81	달리 분류되지 않은 처치의 합병증	Complications of procedures, NEC
T81.0	달리 분류되지 않은 처치에 합병된 출혈 및 혈종	Hemorrhage and hematoma complicating a procedure, NEC
T81.1	달리 분류되지 않은 처치 중 또는 처치에 의한 쇼크	Shock during or resulting from a procedure, NEC
T81.2	달리 분류되지 않은 처치 중의 우발적 천자 또는 열상	Accidental puncture and laceration during a procedure, NEC
T81.3	달리 분류되지 않은 수술 상처의 파열	Disruption of operation wound, NEC
T81.4	달리 분류되지 않은 처치에 의한 감염	Infection following a procedure, NEC
T81.5	처치에 의해 체강 또는 수술상처에 우발적으로 남겨진 이물	Foreign body accidentally left in body cavity or operation wound following a procedure
T81.50	처치에 의해 체강 또는 수술상처에 우발적으로 남겨진 이물, 유착을 동반한	Foreign body accidentally left in body cavity or operation wound following a procedure, with adhesions
T81.51	처치에 의해 체강 또는 수술상처에 우발적으로 남겨진 이물, 폐색을 동반한	Foreign body accidentally left in body cavity or operation wound following a procedure, with obstruction
T81.52	처치에 의해 체강 또는 수술상처에 우발적으로 남겨진 이물, 천공을 동반한	Foreign body accidentally left in body cavity or operation wound following a procedure, with perforation
T81.58	처치에 의해 체강 또는 수술상처에 우발적으로 남겨진 이물, 기타 명시된 합병증을 동반한	Foreign body accidentally left in body cavity or operation wound following a procedure, with other specified complication
T81.59	처치에 의해 체강 또는 수술상처에 우발적으로 남겨진 이물, 상세불명의 합병증을 동반한	Foreign body accidentally left in body cavity or operation wound following a procedure, with unspecified complication
T81.6	처치중 우발적으로 남겨진 이물에 대한 급성 반응	Acute reaction to foreign substance accidentally left during a procedure
T81.81	처치에 의한 (피하)기종	Emphysema (subcutaneous) resulting from a procedure
T81.82	지속적 수술 후 누공	Persistent postoperative fistula
T83	비뇨생식기 인공삽입장치, 삽입물 및 이식편의 합병증	Complications of genitourinary prosthetic devices, implants and grafts
T83.0	요도(유치)카테터의 기계적 합병증	Mechanical complication of urinary (indwelling) catheter
T83.1	기타 요로장치 및 삽입물의 기계적 합병증	Mechanical complication of other urinary devices and implants
T83.2	비뇨기관의 이식물의 기계적 합병증	Mechanical complication of graft of urinary organ
T83.4	생식관의 기타 인공삽입 장치, 삽입물 및 이식편의 기계적 합병증	Mechanical complication of other prosthetic devices, implants and grafts in genital tract
T83.5	비뇨기계통의 인공삽입 장치, 삽입물 및 이식편에 의한 감염 및 염증성 반응	Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system
T83.6	생식관 인공삽입장치, 삽입물 및 이식편에 의한 감염 및 염증성 반응	Infection and inflammatory reaction due to prosthetic device, implant and graft in genital tract
T83.8	기타 비뇨생식기 인공삽 입장치, 삽입물 및 이식 편의 합병증	Other complications of genitourinary prosthetic devices, implant and grafts
T83.9	상세불명의 비뇨생식기 인공삽입장치, 삽입물 및 이식편의 합병증	Unspecified complication of genitourinary prosthetic devices, implant and graft
Z12.5	전립선의 신생물에 대한 특수 선별검사	Special screening examination for neoplasm of prostate
Z12.6	방광의 신생물에 대한 특 수 선별검사	Special screening examination for neoplasm of bladder
Z30.2	불임법	Sterilization
Z31.0	과거의 불임시술 이후의 난관 또는 정관 성형술	Tuboplasty or vasoplasty after previous sterilization
Z52.4	신장기증자	Kidney donor
Z94.0	신장이식 상태	Kidney transplant status
Z71.9	상세불명의 상담을 위해 보건서비스와 접하고 있는 사람	Persons encountering health services for counselling, unspecified